Veiga Ana Beatriz G, Pinto Antônio F M, Guimarães Jorge A
Center of Biotechnology, UFRGS, Av. Bento Gonçalves, 9500, P.O. Box 15005, Porto Alegre 91501-970-RS, Brazil.
Thromb Res. 2003;111(1-2):95-101. doi: 10.1016/j.thromres.2003.08.020.
The hemorrhagic syndrome caused by accidents with caterpillars of the genus Lonomia has been the focus of several clinical and biochemical studies, since its venom is composed of many active principles that interfere with the hemostatic system. Whereas a fibrinolytic agent has been characterized in the venom of Lonomia achelous, in Lonomia obliqua, only a prothrombin activator activity has been reported so far, even though both species cause similar bleeding disorders, characterized by hemorrhage, disseminated intravascular coagulation (DIC), and acute renal failure. Considering the possibility that the hemorrhagic syndrome resulting from envenoming by L. obliqua may be due to fibrinolytic and procoagulant activities acting together, we decided to investigate the effects of bristle extract (BE) of this species upon blood coagulation and fibrin(ogen)olysis. This study shows that besides a procoagulant activity related to the activation of prothrombin, the venom contains at least one fibrin(ogen)olytic activity, as shown by fibrinolysis in a fibrin (F) plate assay, by interference in thrombin-catalyzed fibrinocoagulation, and by polyacrylamide gel electrophoresis profile of fibrin and fibrinogen (Fg) degradation. Considering that a recombinant prothrombin activator from L. obliqua has been suggested in other studies to be used as an anti-thrombotic agent, it is important in the first place to better characterize the different active principles of this venom.
由洛诺米属毛虫叮咬导致的出血综合征一直是多项临床和生化研究的重点,因为其毒液由多种干扰止血系统的活性成分组成。虽然已在螯合洛诺米的毒液中鉴定出一种纤维蛋白溶解剂,但在斜纹洛诺米中,迄今为止仅报道了一种凝血酶原激活剂活性,尽管这两个物种都会引发相似的出血性疾病,其特征为出血、弥散性血管内凝血(DIC)和急性肾衰竭。考虑到斜纹洛诺米毒液导致的出血综合征可能是由于纤维蛋白溶解活性和促凝血活性共同作用的可能性,我们决定研究该物种的刚毛提取物(BE)对血液凝固和纤维蛋白(原)溶解的影响。这项研究表明,除了与凝血酶原激活相关的促凝血活性外,该毒液还含有至少一种纤维蛋白(原)溶解活性,这在纤维蛋白(F)平板试验中的纤维蛋白溶解、对凝血酶催化的纤维蛋白凝固的干扰以及纤维蛋白和纤维蛋白原(Fg)降解的聚丙烯酰胺凝胶电泳图谱中得到了证实。鉴于其他研究已提出将斜纹洛诺米的重组凝血酶原激活剂用作抗血栓药物,首先更好地表征这种毒液的不同活性成分非常重要。